½«ΰͺεξαΗ2iMultiple endocrine neoplasia type 2FMEN2jγΓΜiΰ
Recent Progress in Multiple Endocrine Neoplasia Type 2
Department of Endocrine Surgery, Nippon Medical School
Multiple endocrine neoplasia type 2 (MEN2) is an autosomal, predominantly hereditary disease characterized by medullary thyroid carcinoma, pheochromocytoma, and primary hyperparathyroidism; it is classified into type 2A, type 2B, and familial medullary thyroid carcinoma (FMTC). The last decade has seen improvements in the treatment and management of MEN2 in Japan. The establishment of a Japanese MEN database and the publication of a MEN clinical guidebook have played an important role in promoting effective management of the disease in our country. Our knowledge of MEN2 has expanded greatly, and in this review, I summarize our understanding of the disease based on recent discoveries.
ϊγεγο 2015; 11(1), 6-11
MEN2, endocrine surgery
Takehito Igarashi, Department of Endocrine Surgery, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku Tokyo 113-8623, Japan